BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21030159)

  • 1. Rates of second malignancies after definitive local treatment for ductal carcinoma in situ of the breast.
    Shaitelman SF; Grills IS; Kestin LL; Ye H; Nandalur S; Huang J; Vicini FA
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1244-51. PubMed ID: 21030159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omitting radiation therapy after lumpectomy for pure DCIS does not reduce the risk of salvage mastectomy.
    Rakovitch E; Nofech-Mozes S; Hanna W; Sutradhar R; Gu S; Fong C; Tuck A; Youngson B; Miller N; Done SJ; Chang MC; Sengupta S; Elavathil L; Jani PA; Bonin M; Lalani N; Paszat L
    Breast; 2018 Feb; 37():181-186. PubMed ID: 28781102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Radiotherapy With Survival in Women Treated for Ductal Carcinoma In Situ With Lumpectomy or Mastectomy.
    Giannakeas V; Sopik V; Narod SA
    JAMA Netw Open; 2018 Aug; 1(4):e181100. PubMed ID: 30646103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
    Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term risk of second malignancies in women after breast conservation therapy for ductal carcinoma in situ or early-stage breast cancer.
    Kushner CJ; Hwang WT; Wang S; Solin LJ; Vapiwala N
    Breast Cancer Res Treat; 2018 Jul; 170(1):45-53. PubMed ID: 29488126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationalization and regionalization of treatment for ductal carcinoma in situ of the breast.
    Smith GL; Smith BD; Haffty BG
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1397-403. PubMed ID: 16750316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second cancers after conservative surgery and radiation for stages I-II breast cancer: identifying a subset of women at increased risk.
    Fowble B; Hanlon A; Freedman G; Nicolaou N; Anderson P
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):679-90. PubMed ID: 11597809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women.
    Elshof LE; Schaapveld M; Schmidt MK; Rutgers EJ; van Leeuwen FE; Wesseling J
    Breast Cancer Res Treat; 2016 Oct; 159(3):553-63. PubMed ID: 27624164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypofractionated radiation therapy for breast ductal carcinoma in situ.
    Hathout L; Hijal T; Théberge V; Fortin B; Vulpe H; Hogue JC; Lambert C; Bahig H; Provencher L; Vavassis P; Yassa M
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1058-63. PubMed ID: 24113057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.
    ; ; Bijker N; Meijnen P; Peterse JL; Bogaerts J; Van Hoorebeeck I; Julien JP; Gennaro M; Rouanet P; Avril A; Fentiman IS; Bartelink H; Rutgers EJ
    J Clin Oncol; 2006 Jul; 24(21):3381-7. PubMed ID: 16801628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five year outcome of 145 patients with ductal carcinoma in situ (DCIS) after accelerated breast radiotherapy.
    Ciervide R; Dhage S; Guth A; Shapiro RL; Axelrod DM; Roses DF; Formenti SC
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e159-64. PubMed ID: 22579378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung carcinoma after radiation therapy in women treated with lumpectomy or mastectomy for primary breast carcinoma.
    Zablotska LB; Neugut AI
    Cancer; 2003 Mar; 97(6):1404-11. PubMed ID: 12627503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis.
    Rakovitch E; Nofech-Mozes S; Narod SA; Hanna W; Thiruchelvam D; Saskin R; Taylor C; Tuck A; Sengupta S; Elavathil L; Jani PA; Done SJ; Miller N; Youngson B; Kong I; Paszat L
    Breast Cancer Res Treat; 2013 Apr; 138(2):581-90. PubMed ID: 23456231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of breast-conserving therapy for women with ductal carcinoma in situ.
    Warren LEG; Chen YH; Halasz LM; Brock JE; Capuco A; Punglia RS; Wong JS; Golshan M; Bellon JR
    Breast Cancer Res Treat; 2019 Dec; 178(3):607-615. PubMed ID: 31493031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option.
    Haberer S; Belin L; Le Scodan R; Kirova YM; Savignoni A; Stevens D; Moisson P; Decaudin D; Pierga JY; Reyal F; Campana F; Fourquet A; Bollet MA
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e145-52. PubMed ID: 21605948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypofractionation Is an Acceptable Alternative to Conventional Fractionation in the Treatment of Postlumpectomy Ductal Carcinoma In Situ With Radiotherapy.
    Isfahanian N; Al-Hajri T; Marginean H; Chang L; Caudrelier JM
    Clin Breast Cancer; 2017 Apr; 17(2):e77-e85. PubMed ID: 27889437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome in patients with ductal carcinoma in situ treated with breast-conserving therapy: implications for optimal follow-up strategies.
    Shaitelman SF; Wilkinson JB; Kestin LL; Ye H; Goldstein NS; Martinez AA; Vicini FA
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e305-12. PubMed ID: 22417804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of low-risk ductal carcinoma in situ in Southeast Asian women treated with breast conservation therapy.
    Wong FY; Wang F; Chen JJ; Tan CH; Tan PH
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):998-1003. PubMed ID: 24661651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ: Possible importance of family history.
    Hiramatsu H; Bornstein BA; Recht A; Schnitt SJ; Baum JK; Connolly JL; Duda RB; Guidi AJ; Kaelin CM; Silver EB; Harris JR
    Cancer J Sci Am; 1995; 1(1):55-61. PubMed ID: 9166455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ductal carcinoma in situ (DCIS) treated by mastectomy, or local excision with or without radiotherapy: A monocentric, retrospective study of 608 women.
    Frank S; Dupont A; Teixeira L; Porcher R; De Roquancourt A; Giacchetti S; Espié M; Cuvier C
    Breast; 2016 Feb; 25():51-6. PubMed ID: 26573444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.